baber/WOPTO huggingface dataset:
Patent JP-4026860-B2 (JP)
IPC: A61M25/00
Filed: 1998-10-23
Granted: 2007-12-26
Abstract: A device for removing undesirable material from a tubular structure within the human body features a cylindrical body with a lumen therethrough. The distal portion of the body is divided into a number of flexible members. An inflatable cuff is attached to the flexible members. When the cuff is inflated, the members flex radially outwardly so that the distal opening of the lumen is expanded. An inflation tube is used to inflate and deflate the cuff by means of a syringe. An elastomeric membrane sleeve surrounds the flexible members so that the latter are contracted towards their original position when the cuff is deflated. The sleeve also prevents material from escaping between the flexible members when the cuff is inflated.
Patent JP-2750223-B2 (JP)
IPC: G02B6/44
Filed: 1995-05-05
Granted: 1998-05-13
Abstract: A method for storing rolled-up cables and other windable articles such as hoses, pipes, tubes and other profile sections which are advantageously rolled up in a storage rack. A corresponding storage device (1) is also provided which includes a storage rack (10) consisting of a circular outer wall (12) engaging the rim of a base (11) for supporting the rolled-up cable, a guide assembly (4), and a stationary (20) or rotary (21) positioning member (2) for angularly feeding the article being rolled up (3) from the guide assembly (4) to the storage rack (10). The design of the device is such that no drive is required for the positioning member (2) and the cable (3) is properly arranged in the rack (10) by means of its inherent longitudinal stiffness.
Patent JP-3496938-B2 (JP)
IPC: A61K38/00
Filed: 1997-03-17
Granted: 2004-02-16
Abstract: This invention concerns new non-receptor protein tyrosine phosphatases of the hematopoietic stem cells (PTP HSC). The invention specifically concerns native murine and human PTP HSCs, their analogs in other mammals, and their functional derivatives. The invention further relates to nucleic acid encoding these proteins, vectors containing and capable of expressing such nucleic acid, and recombinant host cells transformed with such nucleic acid. Assays for identifying agonists and antagonists of the native PTP HSCs, methods for expansion of undifferentiated stem cells, and methods for the induction of stem cell differentiation are also within the scope of the invention.
Patent JP-4649602-B2 (JP)
IPC: A61P25/00
Filed: 1998-02-06
Granted: 2011-03-16
Abstract: The present invention relates generally to Activity Dependent Neurotrophic Factor III (ADNF III), also known as Activity Dependent Neuroprotective Protein (ADNP). More particularly, the present invention relates to nucleic acid sequences encoding ADNF III polypeptides; ADNF III polypeptides encoded by such nuclei acid sequences; antibodies to ADNF III polypeptides; and methods of using such ADNF III polypeptides for the treatment of neurological deficiencies and for the prevention of cell death associated with (1) gp 120, the envelope protein from HIV; (2) N-methyl-D-aspartic acid (excito-toxicity); (3) tetrodotoxin (blockage of electrical activity); and (4) ²-amyloid peptide, a substance related to neuronal degeneration in Alzheimer's disease.
Patent JP-4250205-B2 (JP)
IPC: E05D7/10
Filed: 1999-02-08
Granted: 2009-04-08
Abstract: A hinged connection between a removable housing closure and a stationary housing part, wherein a terminal configuration of the housing closure has a convex molding, with a web that is contiguous with the molding and which web has a tapering cross section. Adjacent to the web there is an indentation, in which a convex molding that is on the stationary housing part and is offset at an angle of 90 degrees from a projecting leg and is connected to the projecting leg by a contiguous web that has a tapering cross section is engaged. The housing closure can thereby be pivoted with respect to the stationary housing part and re-engaged with it. Additionally, when the housing is closed, no parts project either inside or outside in the vicinity of the housing closure and the stationary housing part.
Patent ES-2397205-B2 (ES)
Title: Receptor multitubular con radiación solar atrapada
Inventor: MARTINEZ-VAL PENALOSA JOSE MARIA
IPC: F24S20/20
Filed: 2013-01-03
Granted: 2013-09-20
Abstract: Receptor multitubular con radiación solar atrapada.#Dispositivo de múltiples tubos paralelos absorbentes de radiación solar, separados entre sí por un huelgo, al cual se le adiciona una pared posterior reflectante, separada de la parte trasera de los tubos en una distancia determinada, incluyendo en dicha pared unas protuberancias también reflectantes en forma de doble cuña, que coinciden con las zonas de huelgo, y cuyo ángulo de cuña está también especificado en función de la relación entre paso y diámetro de los tubos, y de los ángulos máximos de incidencia con que llega la radiación al receptor, desde el campo de espejos.
Patent AU-2001283911-B2 (AU)
Title: Levelling device with an adjustable width
Inventor: SCHUECKER FRANZ-JOSEF
IPC: C10B37/02
Filed: 2001-06-30
Granted: 2005-08-18
Abstract: The device relates to a device for leveling the coal filled in the retort of a coke oven, comprising a leveler bar ( 2 ) connected with a leveler bar drive ( 1 ) that can be moved into and out of the retort ( 4 ) through a leveling opening ( 3 ), and performs a leveling movement back and forth in the retort ( 4 ). According to the invention, the leveler bar ( 2 ) has a rake blade ( 5 ) on its front end with a width that can be adjusted by an operating device ( 6 ) arranged in the leveler bar ( 2 ).
Patent AU-2001291978-B2 (AU)
Title: Method and device for continuously coating at least a metal strip surface with a single-layer or multilayer crosslinkable polymer fluid film
Inventor: VERHALLE RICHARD
IPC: B05C9/14
Filed: 2001-09-24
Granted: 2005-06-23
Abstract: A method for continuously coating at least one surface of a metal strip with a single-layer or multilayer crosslinkable polymer fluid film (20) obtained from solid precursors at room temperature and free of non-reactive solvent or diluent and whereof the softening temperature is higher than 50° C. The method includes: continuously unwinding the metal strip (1); preheating the metal strip (1) at a temperature substantially equal to or higher than the crosslinkable polymer softening temperature; forming by forced flow on an applicator roll (12) with deformable surface a single-layer or multilayer coat (13) of the crosslinkable polymer; driving in rotation the applicator roll in the same direction as that of the unwinding of the metal strip (1), heating the applicator roll (12) to a temperature higher than the temperature for forming the coat; and transferring the coat onto the metal strip to form the single-layer or mutilayer film (20) on the corresponding surface of the metal strip (1). Also a coating device for implementing the method.
Patent AU-2002234561-B2 (AU)
Title: Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
Inventor: DELEST VERONIQUE
IPC: A23L33/00
Filed: 2001-12-06
Granted: 2007-01-18
Abstract: A method of enzymatically producing a protein hydrolysate from a protein substrate is described, wherein a proline-specific endoprotease or a composition containing a proline-specific endoprotease and optionally a subtilisin or a metallo endoprotease, and other enzymes such as carboxypeptidases, is used to produce a protein hydrolysate enriched in peptide fragments having a carboxy terminal proline residue. Such protein hydrolysates may be used as such or to reduce bitterness in foods nutritionally supplemented by protein hydrolysates, as well as to produce hydrolysate-containing foodstuffs having low antigenicity.
Patent AU-2002337926-B2 (AU)
Title: Stabilization of radiopharmaceuticals labeled with 18-F
Inventor: KISELEV MAXIM Y
IPC: A61K51/04
Filed: 2002-11-05
Granted: 2008-01-31
Abstract: The present invention relates to a radiopharmaceutical composition comprising:  18 F isotope-labeled FDG in water having an activity concentration; and 
ethanol with a final product concentration in the range of a minimum effective stabilization amount up to a practical pharmacopoeia limit.
Patent AU-2002355852-B2 (AU)
Title: Expression profile of prostate cancer
Inventor: CHINNAIYAN ARUL M
IPC: G01N33/15
Filed: 2002-08-02
Granted: 2007-01-18
Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides gene expression profiles associated with prostate cancers. Genes identified as cancer markers using the methods of the present invention find use in the diagnosis and characterization of prostate cancer. In addition, the genes provide targets for cancer drug screens and therapeutic applications.
Patent AU-2002359093-B2 (AU)
Title: Process for the preparation of 2-(6-substituted-1,3-dioxane-4-YL) acetic acid derivatives
Inventor: HOF ROBERT PATRICK
IPC: C07B61/00
Filed: 2002-12-09
Granted: 2008-11-13
Abstract: The invention relates to a process for the conversion of group X in a 2-(6-substituted)-1,3-dioxane-4yl) acetic acid derivative according to formula 2 into a group OY in the presence of a phase transfer catalyst and an oxylating agent, by using as a phase transfer catalyst a quarternary phosphonium ion and by using as an oxylating agent an OY<-> ion. X stands for a halogen and R<1>, R<2> and R<3> are each independently a C1-4 alkylgroup or R<1> and R<2> together with the C-atom to which they are bound form a 5- or 6-membered cycloalkyl; Y stands for R<A>-CO- or for R<B>-SO2- with R<A>, R<B> are chosen from the group of alkyl or aryl with 1-12 C-atoms. <IMAGE>
Patent AU-2003256044-B2 (AU)
Title: Fungicide composition containing tea tree oil
Inventor: REUVENI MOSHE
IPC: A61K36/61
Filed: 2003-09-01
Granted: 2005-07-07
Abstract: A novel fungicidal emulsion is presented. This emulsion comprising tea tree essential oil and a water emulsion wherein the emulsifier is a water solution of a reaction product of a high molecular weight organic fatty acid and an alkali or ammonium compound.
Patent AU-2003290841-B2 (AU)
Title: A method for fast, secure 802.11 re-association without additional authentication, accounting, and authorization infrastructure
Inventor: REBO RICHARD D
IPC: H04L12/28
Filed: 2003-11-13
Granted: 2010-01-21
Abstract: A method wherein an access point authenticates itself with neighboring access points and establishes secure and mutually authenticated communication channels with its neighboring access points. When an access point learns of a neighboring access point, it initiates an authentication with an authentication server through the neighboring access point. Once access points have mutually authenticated each other, whenever a station authenticates itself with a first access point, the first access point communicates the station's authentication context information, for example session key and session identifier, to each neighboring access point. Thus, when the station roams to a neighboring access point, the neighboring access point presents the station with a reauthentication protocol, for example LEAP reauthentication, and if the reauthentication is successful, communication between the station and the neighboring access point takes place immediately and no new EAP authentication needs to occur.
Patent AU-2003302609-B2 (AU)
Title: Novel chi-conotoxin peptides (-I)
Inventor: ALEWOOD DIANNE
IPC: A61P9/00
Filed: 2003-12-02
Granted: 2008-03-20
Abstract: An isolated, synthetic or recombinant χ-conotoxin peptide comprising the following sequence of amino acids: Xaa1 Xaa2 Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys SEQ ID NO. 3 where Xaa1 is a N-terminal Xaa1 is a N-terminal pyroglutamate (pGlu) or D-pyroglutamate (DpGlu) residue; and Xaa2 is Asn or a deletion; or such a sequence in which one or more Cys is replaced with its corresponding D-amino acid and/or one or more amino acid residues other than Cys has undergone a side chain modification, or a salt, ester, amide or prodrug thereof. The invention also relates to pharmaceutical compositions comprising these peptides and the use of these peptides in the prophylaxis or treatment of conditions, such as but not limited to, pain, inflammation, incontinence, cardiovascular conditions and mood disorders.
Patent AU-2004214376-B2 (AU)
Title: Method for creating and distributing cryptographic keys in a mobile radio system, and corresponding mobile radio system
Inventor: HORN GUNTHER
IPC: H04L9/32
Filed: 2004-02-18
Granted: 2009-09-03
Abstract: A first cryptographic key (318) and a second cryptographic key (322) are created by a mobile radio terminal (103) and by a computer of the home communications network (108, 109) by using authentication key materials (312). The first cryptographic key (318) is transmitted to the computer of the visited communications network (113), and the second cryptographic key (322) is transmitted to an application server computer (106, 107).
Patent AU-2004244825-B2 (AU)
Title: A joint for fluid transport lines for medical use
Inventor: BARALDI VINCENZO
IPC: A61M1/16
Filed: 2004-05-31
Granted: 2010-06-17
Abstract: The joint (36) comprises a tubular body (37) having two connecting zones (38, 39) each connected by an end to a tubular element (40) of a fluid transport line, giving continuity to passage of fluid. The tubular body is made of a mixture of an electrically-conductive material such as PVC, with carbon black to give it electrical conductivity. The joint has an internal surface (41) which is destined to come into contact with the transported fluid, and an external surface which is destined to have a grounded galvanic contact. The joint eliminates ECG artefacts due to functioning of peristaltic pumps in a dialysis apparatus.
Patent AU-2005220220-B2 (AU)
Title: Electrosurgical system employing multiple electrodes and method thereof
Inventor: BUYSSE STEVEN P
IPC: A61B18/14
Filed: 2005-10-06
Granted: 2011-10-13
Abstract: ELECTROSUGICAL SYSTEM EMPLOYING MULTIPLE ELECTRODES AND METHOD THEREOF A system (E) and method for heat ablation of tissue in which energy is sequentially applied to at lest two electrodes inserted into tissue. The system is comprised of a radiofrequency (RF) source (116) for supplying RF energy, at least two electrodes (101-103) configured to apply RF energy to tissue (T), at least one return electrode (101 1o 103) for returning the RF energy to the RF source, and a controller (117) configured to sequentially apply the RF energy to each of the at least two electrodes. The sequential delivery of energy is determined by the measured current and voltage, the calculated impedance at each of the electrodes and the timing for each electrode. An internal load may be activated with the previously activated channel and remain on until the next is channel is activated to avoid the generator from having an open circuit. CC~j '.-. ij:>
Patent AU-2005287215-B2 (AU)
Title: Compounds for the treatment of dyslipidemia and other lipid disorders
Inventor: DROPINSKI JAMES F
IPC: A61K31/42
Filed: 2005-09-12
Granted: 2011-04-07
Abstract: A class of compounds having Formula I and pharmaceutically acceptable salts thereof are useful as therapeutic compounds, particularly in the treatment of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of developing conditions and sequelae that are associated with these diseases, such as atherosclerosis.
Patent AU-2005325198-B2 (AU)
Title: Anti-drawback medical valve
Inventor: COTE SR ANDREW L
IPC: A61M39/04
Filed: 2005-06-10
Granted: 2011-05-19
Abstract: A medical valve has an interior flow path having a volume that is substantially the same when in either the closed mode (when the valve is closed) or the open mode (when the valve is open). To those ends, the medical valve has a housing forming an interior, and a valve mechanism (within the interior) having a substantially rigid translating member with a bore. The interior of the housing has a flow path that includes at least a portion of the bore of the translating member. As noted above, the open mode volume is substantially equal to the closed mode volume.
Patent AU-2006235022-B2 (AU)
Title: Mitotic kinesin inhibitors
Inventor: COX CHRISTOPHER D
IPC: A61K31/415
Filed: 2006-04-03
Granted: 2011-07-21
Abstract: The present invention relates to fluorinated dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
Patent AU-2006308436-B2 (AU)
Title: Specific expression using transcriptional control sequences in plants
Inventor: LOPATO SERGIY
IPC: A01H1/06
Filed: 2006-10-27
Granted: 2012-08-16
Abstract: The present invention relates generally to methods and transcriptional control sequences suitable for effecting expression of a nucleotide sequence of interest in a plant. More particularly, the present invention relates to methods and transcriptional control sequences suitable for directing specific or preferential expression of a nucleotide sequence of interest in a plant seed. Of particular interest as a transcriptional control sequence in this invention is the promoter PR602 (SEQ ID NO: 1) found in the 5 '-untranslated region of the rice ENDl-like gene and isolated from a rice panicle library.
Patent AU-2006325484-B2 (AU)
Title: Biodegradable continuous filament web
Inventor: CONRAD JOHN H
IPC: D01F8/14
Filed: 2006-04-07
Granted: 2012-05-10
Abstract: A biodegradable nonwoven web comprising substantially continuous multicomponent filaments is provided. The filaments comprise a first component and a second component. The first component contains at least one high-melting point aliphatic polyester having a melting point of from about 160° C to about 250° C and the second component contains at least one low-melting point aliphatic polyester. The melting point of the low-melting point aliphatic polyester is at least about 30° C less than the melting point of the high-melting point aliphatic polyester. The low-melting point aliphatic polyester has a number average molecular weight of from about 30,000 to about 120,000 Daltons, a glass transition temperature of less than about 25° C, and an apparent viscosity of from about 50 to about 215 Pascal-seconds, as determined at a temperature of 160° C and a shear rate of 1000 sec.
Patent AU-2006334532-B2 (AU)
Title: Drying apparatus
Inventor: HARTLEY MARCUS LEE
IPC: A47K10/48
Filed: 2006-11-29
Granted: 2010-12-23
Abstract: A drying apparatus includes an outer case, a portion of the outer case defining a cavity in which articles can be dried and an outlet disposed at the lower end of the cavity. A removable liquid treatment module is arranged downstream of the outlet and within the outer case, the liquid treatment module including a liquid dispersal unit. By providing a liquid treatment module that is removable, the liquid treatment module can be easily and quickly replaced by an unskilled user without undue burden. The invention is particularly suitable for use in a hand dryer.
Patent AU-2006340808-B2 (AU)
Title: Pneumatic bioreactor
Inventor: GREGORY ZEIKUS J
IPC: B01F33/40
Filed: 2006-10-24
Granted: 2011-09-01
Abstract: A pneumatic bioreactor includes a vessel containing a fluid to be mixed and at least one mixing device driven by gas pressure. A first embodiment includes a floating impeller that rises and falls In the fluid as gas bubbles carry it upward to the surface where the gas is then vented, permitting the impeller to sink in the fluid. The floating impeller may be tethered to a second impeller with a flexible member and pulley. The mixing speed is controlled with electromagnets in the vessel acting upon magnetic material in the impeller or its guides. In another embodiment, floating pistons mix the fluid, pushing it through a mixing plate with one or more apertures. In a third embodiment, the mixing device is a rotating drum vvith bubble-catching blades and rotating mixing plates with apertures. The top of the vessel for these mixers may include a closed top and sterile filters.
Patent AU-2006342007-B2 (AU)
Title: Geopolymeric particles, fibers, shaped articles and methods of manufacture
Inventor: HOJAJI HAMID
IPC: C04B14/46
Filed: 2006-12-06
Granted: 2012-05-10
Abstract: Shaped geopolymeric particles, fibers, and articles incorporating at least one geopolymer are provided; the geopolymeric particles, fibers, and articles having a structure that is solid, foamed, hollow or with one or more voids. Geopolymers are formed by alkali activation of an aluminosilicate and/or aluminophosphate material. The end-products are shaped as spheres, flakes, fibers, aggregates thereof or articles. Such products are formed at low temperatures; wherein forming includes processing using techniques such as spray drying, melt spinning, or blowing. The shaped geopolymeric particles and fibers have high chemical durability, high mechanical strength, application-targeted flowability and packing properties, and are specially suited for incorporating into composite materials, articles, and for use in cementitious, polymeric, pain:, printing, adhesion and coating applications. Shaped geopolymeric particles, fibers and articles having voids, hollow or foam-like structures are formed by adding one or more blowing agents.
Patent AU-2007210273-B2 (AU)
Title: End-cap device for high efficiency disposable chromatography column
Inventor: BOUIS PAUL A
IPC: G01N30/60
Filed: 2007-01-04
Granted: 2011-10-06
Abstract: A low cost re-usable end-cap for disposable chromatographic columns or solid phase extraction cartridges that simultaneously provide sealing of the column and axial compression, and chromatography columns and solid phase extraction cartridges employing such re-usable end caps.
Patent AU-2007229482-B2 (AU)
Title: Process for making ophthalmic lenses
Inventor: FORD JAMES D
IPC: B29D11/00
Filed: 2007-03-23
Granted: 2012-06-14
Abstract: The present invention relates to aqueous processes for the production of silicone hydrogel contact lenses.
Patent AU-2007313849-B2 (AU)
Title: Flavor releasing cores and their use in chewing gum
Inventor: SEIELSTAD DONALD A
IPC: A23L27/00
Filed: 2007-10-18
Granted: 2010-06-10
Abstract: Flavor releasing structures for chewing gum have about 30% to about 60% thermoplastic cellulose material, about 5% to about 50% non-cellulosic thermoplastic polymer, and about 10% to about 40% porous flavor reservoir material. Optionally the flavor releasing structure may comprise about 5% to about 25% plasticizer. The cores may be coated with a flavor barrier coating.
Patent AU-2007324837-B2 (AU)
Title: Device for equalizing pressure surges in closed systems, such as silos or the like
Inventor: THORWESTEN ALBERT
IPC: B65D90/22
Filed: 2007-11-27
Granted: 2013-03-07
Abstract: With a device (1) for equalizing pressure surges in cases of possible dust or gas explosions in closed systems, such as silos, pipelines or the like, comprising a hinged cover (3) which can be pivoted on an outlet connection or a closing edge (2) and has a smooth outer surface (12) and comprising a deflecting plate (8) on the outlet connection or on the closing edge (2) for the cover (3) to strike against in the event of an explosion, it is intended to achieve not only cost-effective production but also in particular a significant weight saving of the hinged cover, quick changing of the cover in the case of damage, or quick fitting of the cover in the first instance, and an improvement in the protective effect of the system. This is achieved by the hinged cover (3) being made of a carbon/glass-fibre material.